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Background: Assessing temporal variations in transmission in 
different countries is essential for monitoring the epidemic, evaluating 
the effectiveness of public health interventions and estimating the 
impact of changes in policy. 
 
Methods: We use case and death notification data to generate daily 
estimates of the time-varying reproduction number globally, 
regionally, nationally, and subnationally over a 12-week rolling 
window. Our modelling framework, based on open source tooling, 
accounts for uncertainty in reporting delays, so that the reproduction 
number is estimated based on underlying latent infections. 
 
Results: Estimates of the reproduction number, trajectories of 
infections, and forecasts are displayed on a dedicated website as both 
maps and time series, and made available to download in tabular 
form. 
 
Conclusions:  This decision-support tool can be used to assess 
changes in virus transmission both globally, regionally, nationally, and 
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subnationally. This allows public health officials and policymakers to 
track the progress of the outbreak in near real-time using an 
epidemiologically valid measure. As well as providing regular updates 
on our website, we also provide an open source tool-set so that our 
approach can be used directly by researchers and policymakers on 
confidential data-sets. We hope that our tool will be used to support 
decisions in countries worldwide throughout the ongoing COVID-19 
pandemic.
Keywords 
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number, forecasting
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Introduction
The coronavirus disease 2019 (COVID-19) pandemic that 
emerged in December 2019 has since spread to over 100 coun-
tries in every continent except Antarctica. While some infor-
mation on the progress of an outbreak in a given country can 
be gained from the reported numbers of confirmed cases and 
deaths, these numbers can obscure changes in the underlying 
dynamics of the outbreak due to delays between infection 
and the eventual reporting of a case or death. Accounting for 
the uncertain delays from infection to symptom onset, and the 
uncertain delays from symptom onset to hospital admis-
sion, diagnostic testing or potential death, followed by further 
delays until data are recorded in official statistics, requires the 
use of specific statistical methods for handling right-truncated 
data1–3, uncertainty, and the creation of a “nowcast”4,5 (an esti-
mate of the current number of newly infected or symptomatic 
cases).
A method for tracking the progress of an outbreak is to meas-
ure changes in the time-varying reproduction number (effec-
tive reproduction number), which represents the average 
number of secondary infections generated by each new infec-
tious case6–8. This approach can be advantageous compared to 
monitoring numbers of newly reported or symptomatic cases 
since, in principle, reproduction number estimates reflect 
variations in transmission intensity. Due to the delays in disease 
progression, recorded numbers of newly notified or sympto-
matic cases will increase or decrease for a period after trans-
missibility has reduced or increased, respectively. Monitoring 
changes in the time-varying reproduction can account for this 
delay and reveals variations in transmissibility that are not 
clear when using only reported cases.
This paper outlines the methods used to produce the website 
(https://epiforecasts.io/covid/), and data resource9, we have 
developed that presents real-time estimates and forecasts of 
reported cases by date of infection and the respective time-
varying reproduction numbers globally, regionally, nationally 
and subnationally for Covid-19. This website relies on methods 
implemented in the EpiNow2 R package and data aggregated 
in the covidregionaldata R package, both developed 
by the authors10,11. Our estimates overcome some of the 
limitations of naive implementations that derive estimates for 
the reproduction number directly from numbers of reported 
cases without adjusting (or with only partial adjustments) for 
the delay from infection to symptom onset or from onset to 
notification. Our approach also incorporates multiple sources 
of uncertainty that if excluded can bias estimates. The code 
that creates and updates the website is open source, and 
documented for use by others, allowing policymakers and 
researchers to run analyses using confidential data. The 
methods outlined in this paper and corresponding code base 
are under development, and new versions of this live article 
will be released alongside changes to the methods to create a 
record of the methodology used throughout the pandemic.
Methods
Data
We use daily counts of confirmed cases and deaths reported 
by the European Centre for Disease Control from the last 
12 weeks for all analyses conducted at the national level11,12. 
To estimate the delay from symptom onset to reporting (once 
confirmed with a positive laboratory test), we use all cases from 
a publicly available linelist for which onset and notification 
dates are available11,13. This linelist combines all known linelist 
data from over 100 countries at the time of writing. Countries 
are only included in the reported estimates if within the 
last 12 weeks they have fewer than 14 days with non-zero 
case counts. This restriction reduces the likelihood of spuri-
ous estimates for countries with limited transmission or case 
ascertainment.
For sub-national analyses, the data is aggregated using 
the covidregionaldata R package developed by the 
authors. Individual data sources are reported on the respective 
pages of our website. The data are fetched from government 
departments or from individuals who maintain a data source 
if no official data are available. Similarly to national estimates, 
subnational areas are only included if they report at least 
14 days with non-zero cases in the last 12 weeks.
All analyses described below are run daily for each national or 
subnational entity under consideration. An automated times-
tamp is used to evaluate if data has been updated since the 
last time estimates were made in order to avoid repeatedly 
estimating based on the same data.
Delays between case onset and report
To estimate the reporting delay (i.e the delay between onset 
and case report or death) with appropriate uncertainty, we fit 
a log-normal distribution, using use the statistical modelling 
program stan10,14, to 100 subsampled bootstraps (each with 
250 samples drawn with replacement) of the available delay 
data. Accounting for left and right censoring occurring in 
the data as each date is rounded to the nearest day and trun-
cated to the maximum observed delay. There was insufficient 
data available on the various reporting delays to estimate spa-
tially- or temporally-varying delays whilst also accounting 
for the biases induced by the growth rate of reported cases, 
          Amendments from Version 1
In this update we include details of our new open-source 
time-varying reproduction method that is based on inferring 
latent infections rather than attempting to reconstruct them 
via backsampling as discussed in the previous version of this 
article. This approach reduces bias in estimates and increases 
the potential for rapid changes over time. We also discuss, and 
provide links to, our flexible scheduling framework, which is 
developed in partnership with the Met office, and our dataverse, 
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so they were considered to be static over the 12 weeks of 
data considered each day.
This results in an onset to case report delay distribution with 
a mean of 6.5 days and a standard deviation of 17 days and 
an onset to death report delay distribution with a mean of 
13.1 days and a standard deviation of 11.7 days. For computa-
tional reasons the maximum allowed delay is set to be 30 days. 
Dataset specific estimates are detailed on the respective 
country pages. Estimated delays are routinely updated as new 
data becomes available.
As data may also be right truncated due to unrecorded delays 
(i.e the delay between a case report and its appearance in an 
aggregated data set) we truncate all time-series to exclude 
the last 3 days of data, based on qualitative inspection of the 
stability of case counts in the datasets used.
Estimating the time-varying reproduction number and 
nowcasting reported infections
We estimated the instantaneous reproduction number (R
t
) 
using the EpiNow2 R package (version 1.2.1)10 on the last 
12 weeks of available data, discarding estimates from the first 
14 days globally, for United Nation regions, nationally, and 
subnationally for 10 countries. The instantaneous reproduction 
number represents the number of secondary cases arising 
from an individual showing symptoms at a particular time, 
assuming that conditions remain identical after that time, and 
is therefore a measure of the instantaneous transmissibility (in 
contrast to the case reproduction number - see Fraser (2007)8 
for a full discussion). EpiNow2 implements a Bayesian 
latent variable approach using the probabilistic programming 
language Stan14, which works as follows. The initial number 
of infections were estimated as a free parameter with a prior 
based on the initial number of cases, or deaths, respectively. 
For each subsequent time step, previous imputed infections 
(I
t–1
) were summed, weighted by an uncertain generation 
time probability mass function (w), and combined with an 
estimate of R
t
 to give the incidence at time t (I
t
)6,7,10. We used a 
log normal prior for the reproduction number (R
0
) with mean 
1 and standard deviation 1 reflecting our current belief that 
R
t
 is likely to be centered around 1 in most of the world, 
with public health interventions and individual behaviour 
combining to prevent it from growing significantly larger for 
sustained periods. This contrasts with our earlier approach 
which was to use a gamma prior with a of mean 2.6 and standard 
deviation 2. This was based on early estimates for the basic 
reproduction number from the initial stages of the outbreak 
in Wuhan15,16 with long tails to allow for differences in the 
reproduction number between countries. The infection 
trajectories were then mapped to mean reported case counts 
(D
t
) by convolving over an uncertain incubation period and 
report delay distribution (convolved into ξ). Observed reported 
case counts (C
t
) were then assumed to be generated from a 
negative binomial observation model with overdispersion ϕ 
(using an exponential prior with mean 1) and mean D
t
, 
multiplied by a day of the week effect with an independent 
parameter for each day of the week (ω
(tmod7)
). Temporal variation 
was controlled using an approximate Gaussian process17 with 
a squared exponential kernel (GP). In mathematical notation,
mod7
1~ GP
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The parameters of the Gaussian process kernnl were esti-
mated during model fitting with the following priors. The length 
scale was given an inverse gamma prior with shape and scale 
values optimised to give a distribution with 98% of the den-
sity between 2 days and 21 days. The prior on the magnitude 
was standard normal. Each timeseries was fit independently 
using Markov-chain Monte Carlo (MCMC). A minimum 
of 4 chains were used with a warmup of 500 each and 4000 
samples post warmup. Convergence was assessed using the 
R hat diagnostic14.
We used an estimate of the generation time sourced from18 
but refit using a log-normal incubation period with a mean of 
5.2 days (SD 1.1) and SD of 1.52 days (SD 1.1)19 rather than 
the incubation period used in the original study (code avail-
able here: https://github.com/seabbs/COVID19). This resulted 
in a distributed generation time with mean 3.6 days (standard 
deviation (SD) 0.7), and SD of 3.1 days (SD 0.8) for all esti-
mates. The incubation period estimate was also used to con-
volve from unobserved infections to unobserved onsets in 
the model. See 10 for further details on the approach.
Estimating the daily growth rate and doubling time
We estimated the rate of spread (r) by converting our R
t
 esti-
mates using an approximation derived in 20. The doubling time 
was then estimated by calculating ln(2) 1
r
 for each estimate 
of the rate of spread.
Estimated change in daily cases
We defined the estimated change in daily cases to correspond 
to the proportion of reproduction number estimates for the 
current day that are below 1 (the value at which an outbreak 
is in decline). It was assumed that if less than 5% of sam-
ples were subcritical then an increase in cases was definite, if 
less than 20% of samples were subcritical then an increase in 
cases was likely, if more than 80% of samples were subcriti-
cal then a decrease in cases was likely and if more than 95% 
of samples were subcritical then a decrease in cases was 
definite. For countries/regions with between 20% and 80% 
of samples being subcritical we could not make a statement 
about the likely change in cases (defined as unsure).
The effect of changes in testing procedure
The results presented here are sensitive to changes in 
COVID-19 testing practices and the level of effort put into 
detecting COVID-19 cases, e.g. through contact tracing. For 
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example, if numbers of incident infections remain constant but 
a country begins to find and report a higher proportion of cases, 
then an increasing value of the reproduction number will be 
inferred. This is because all changes in the number of cases 
are attributed to changes in the number of infections result-
ing from previously reported cases and are not assumed to be a 
result of improved testing and surveillance. On the other hand, 
if a country reports a lower proportion of cases because a 
lower number of tests are performed (which can happen if rea-
gents required for testing are no longer available, for exam-
ple) or the surveillance system captures a lower proportion 
of infections, then the model will attribute this to a drop in 
the reproduction number that may not be a true reduction. In 
order for our estimates to be unbiased not all cases have to 
be reported, but the level of testing effort (and therefore the 
proportion of detected cases) must be constant21. This means 
that, whilst a change in testing effort will initially intro-
duce bias, this will be reduced over time as long as the 
testing effort remains consistent from this point onwards.
Countries may also change the focus of their surveillance over 
the course of the outbreak. They may initially focus on iden-
tifying travellers returning from areas of known COVID-19 
transmission and performing contact tracing on the contacts 
of known cases. As the outbreak evolves this may change to 
passive surveillance at hospitals. Here, the case definition 
may also change from tests based on polymerase chain reac-
tion (PCR) to diagnoses based on symptoms and computed 
tomography (CT) scans. In the future, different kinds of 
COVID-19 tests may be deployed that could influence results, 
such as tests that detect both active and past infections.
Forecasting the reproduction number and case counts 
by date of infection
We forecast the time-varying effective reproduction number 
over a 14-day time horizon by assuming it remains the same 
as the last estimated R
t
. The reproduction number forecast 
is then transformed into a case forecast using the EpiNow2 
model outlined in the previous section10. These forecasts are 
indicative only and should not be considered with a weight 
equal to the real-time estimates. Changes in contact rates, 
mobility, and public health interventions are not accounted for 
which may lead to significant inaccuracy.
Reporting
We report the median and 90% credible intervals for all meas-
ures with 20%, 50% and 90% credible intervals shown in 
figures. The analysis was conducted independently for all 
regions and is updated daily as new data becomes available. 
To highlight the proportion of cases that have yet to be reported 
(due to correcting for right truncation), we show a cut-off in 
figures based on the mean of all delays. Values prior to this 
point are defined as estimates with values past this point 
being defined as estimates based on partial data. In reality, 
this is a continuum with estimates closer to now progressively 
being based on less data and therefore becoming increasing 
uncertain. All estimates are available as downloadable files 
in csv format under an open-source license for use elsewhere9. 
The scheduling framework used to update our estimates is also 
available under an open-source license (https://github.com/ 
epiforecasts/covid-rt-estimate).
Website, summarised estimates, and interactivity
We use Rmarkdown templates and the distill framework to 
generate webpages summarising these estimates22,23. The RtD3 
package is used to provide interactive visualisations of all 
estimates24. Estimates by country are provided on a dedicated 
static page along with global, and regional, summaries. More 
detailed subnational estimates are available for over 10 countries 
in an flexible framework into which additional subnational 
estimates will be added as more data becomes available.
Discussion
We provide a centralised resource which generates compara-
ble daily estimates of the time-varying reproduction number 
and a daily nowcast of the number of cases newly infected 
derived using a standardised method. We account for the 
delay between infection and case notification and include all 
sources of quantifiable uncertainty. This resource may be use-
ful for policymakers to track the progression of the COVID-19 
outbreak and evaluate the effectiveness of intervention meas-
ures. As new data become available, we will include sub-
national estimates for additional countries, and provide 
additional support for public health agencies or researchers 
interested in applying our methods to their data.
There are several advantages associated with our approach. 
Firstly, reported counts are the only data required, which allows 
our approach to be used in a wide variety of contexts. It can 
be applied separately to counts of cases, hospital admissions, 
deaths or other metrics as long as appropriate delay distribu-
tions are used25. As our methodology is applied across a range 
of geographies our estimates can be compared without having 
to consider differences in the underlying approach (even if 
differences in testing should still be accounted for as discussed 
below). Finally, we have constructed our approach using open 
source tools and all of our code, raw data, and results are 
available online and developed with other users in mind. This 
means our methods can be readily applied by others to non- 
public data and be fully evaluated by end users.
Our approach is also subject to several limitations. Firstly, 
the model requires that the proportion of infections that are 
notified is constant over the 12 weeks considered. In other 
words, it requires consistency in the focus of the surveil-
lance method, level of effort spent on testing, and case defini-
tion. Yet it is often the case that the level of under-reporting in a 
country changes over the course of an outbreak21. However, it 
should be noted that any changes in surveillance testing pro-
cedures will only bias the estimates temporarily if they begin 
to remain consistent again after they have changed. How long 
the bias remains in the reproduction number estimates will 
depend on the serial generation time and delay distributions, 
as well as the length scale of the Gaussian process used in 
the reproduction number estimation process. The impact of 
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testing and other reporting biases vary between measures 
of transmission (test positive cases, hospital admissions, test 
positive deaths)25. For this reason we include estimates based 
on reported deaths and provide tooling to allow estimates to 
be produced for alternative datasets. In theory, estimates from 
disparate sources should be comparable using our approach, 
however if they in fact represent different sub-populations 
then there may be variation between them that can potentially 
be usefully interpreted.
In addition, the model is limited by how representative the 
delay that we use from infection to notification distribution is 
for a given location. As there is limited data to assess this, we 
estimate a bootstrapped global delay distribution using the com-
bined data from every country. In particular, the delay from 
onset to notification can especially impact the upscaling of 
cases by date of onset that accounts for cases that have onset 
but not yet been reported. If the true delay from onset to noti-
fication for a given country is shorter than our global delay, 
then we will overestimate onset case numbers, and vice 
versa for true delays longer than the distribution we used. 
Additionally, estimates of the reporting delay distribution 
are known to be biased early in an epidemic and may vary 
over time26. However, our use of a bootstrapped subsampling 
approach mitigates these issues by allowing multiple delay dis-
tributions based on the observed data to be considered at the 
cost of increasing uncertainty in our estimates.
Our model is also limited by the data available to us. For 
example, the publicly available linelists contain little data on 
the importation status of cases. This means that cases counts 
may be biased upwards by attributing imported cases to local 
transmission. This bias is particularly problematic when case 
counts are low. Unfortunately, in the absence of data, this issue 
can only be explored via scenario analysis.
As more data becomes available, future work should look 
to refine the distributions used for generation time, incuba-
tion period, and the report delay. There is also the poten-
tial to extend the present model to account for changes in the 
delay from onset to notification over the course of an out-
break though additional data would need to be available for this 
to be possible. Finally, there is scope to explore how out-
break dynamics that differ among particular sub-populations, 
such as high-risk COVID-19 patients, can bias overall repro-
duction number estimates. This may be achieved by com-
paring reproduction number estimates from disparate data 
sources such as test positive cases, hospital admissions, and 
test positive deaths.
Our approach, providing real-time estimates of the reproduc-
tion number, serves as a valuable tool for decision makers look-
ing to track the course of COVID-19 outbreaks. The nowcasts 
explicitly account for delays, using the same methodology 
across all countries and sub-national regions. These reproduc-
tion number estimates may also be used to ascertain the likely 
outbreak trajectory if no policy interventions are made. They 
can also provide real-time feedback on whether transmission 
is decreasing following a particular intervention, or whether 
it is increasing following the relaxing or lifting of cur-
rent intervention measures. We hope that our website and the 
related toolkit will provide a valuable resource for devising 
strategies to contain COVID-19 outbreaks worldwide.
Data availability
Latest data: https://dataverse.harvard.edu/dataverse/covid-rt





•    Website (Front-end): https://github.com/epiforecasts/covid
•     Scheduling framework: https://github.com/epiforecasts/covid-
rt-estimates
•     EpiNow2 R package (R estimation, data processing, visualisa-
tion and reporting): https://github.com/epiforecasts/EpiNow2
•     covidregionaldata R package (data aggregation and processing): 
https://github.com/epiforecasts/covidregionaldata
•     RtD3 R package (interative visualisation): https://github.com/
epiforecasts/RtD3
Archived at the time of publication
•    Website: https://doi.org/10.5281/zenodo.3841818
•     Scheduling framework: https://github.com/epiforecasts/covid-
rt-estimates
•    EpiNow2 R package10: https://doi.org/10.5281/zenodo.3957489
•     covidregionaldata R package11: https://doi.org/10.5281/zen-
odo.3957539
•    RtD324: https://doi.org/10.5281/zenodo.4011841
License: MIT
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